BIIB vs FSBC · P/E 21, rev $9.89B vs P/E 14, rev $139.7M
Biogen Inc (BIIB) versus Five Star Bancorp (FSBC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Five Star Bancorp (FSBC) is a banks - regional company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FSBC revenue for 2026-06-30 was $139.7M. Net income was $38.0M. FSBC currently screens at market cap $963.6M and trailing P/E 14.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FSBC currently screens at market cap $963.6M and trailing P/E 14.3.
Not investment advice. Open the BIIB and FSBC stock pages for the full models.
Not investment advice.